8-KEarnings & ResultsExhibits & Filings

AMGEN INC 8-K Report, Financial Results (Jan 28, 2016)

Filed January 28, 2016For Securities:AMGN

Summary

Amgen Inc. (AMGN) filed an 8-K on January 28, 2016, to report its unaudited financial results for the fourth quarter and full year ended December 31, 2015, along with its financial position as of that date. The report primarily directs investors to a press release (Exhibit 99.1) for detailed financial information, including both GAAP and non-GAAP measures. Of particular note for investors is the company's inclusion and explanation of non-GAAP financial measures such as adjusted earnings per share, free cash flow, and adjusted operating income. Amgen's management provides a rationale for using these non-GAAP figures, asserting they offer valuable insights into the company's financial condition and operational performance, and are used internally for decision-making. Investors should review the accompanying press release for the specific financial figures and the reconciliation between GAAP and non-GAAP metrics.

Key Highlights

  • 1Amgen announced its unaudited financial results for the three months and year ended December 31, 2015.
  • 2The company provided its unaudited financial position as of December 31, 2015.
  • 3The 8-K filing incorporates by reference a press release dated January 28, 2016, containing the detailed financial results.
  • 4Amgen included and explained several non-GAAP financial measures in its press release.
  • 5Key non-GAAP measures disclosed include adjusted earnings per share and free cash flow.
  • 6Management provided reasons why these non-GAAP measures are considered useful for investors and for internal decision-making.
  • 7The press release contains reconciliations between the non-GAAP measures and the most directly comparable GAAP financial measures.

Frequently Asked Questions

The main purpose of this 8-K filing is to announce and provide access to Amgen's unaudited financial results for the fourth quarter and full year ended December 31, 2015, and its financial position as of that date. The detailed information is presented in an accompanying press release.

Non-GAAP financial measures are financial metrics that exclude or include amounts that are different from the most directly comparable measure calculated under Generally Accepted Accounting Principles (GAAP). Amgen is discussing these measures because its management believes they provide useful information to investors about the company's financial condition and results of operations, and they are also used by management for internal decision-making.

The specific unaudited financial results, including GAAP and non-GAAP figures, for the three months and year ended December 31, 2015, are detailed in the press release dated January 28, 2016, which is filed as Exhibit 99.1 to this 8-K.

No, this 8-K filing, along with the accompanying press release, reports unaudited financial results and financial position for the period ended December 31, 2015. Audited financial statements are typically presented in the company's Annual Report on Form 10-K.